Avid Bioservices Depreciation & Amortization 2011-2026 | CDMO

Annual Depreciation & Amortization Avid Bioservices

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
11.1 M	7.21 M	4.48 M	3.45 M	3.09 M	2.75 M	2.56 M	2.46 M	1.54 M	1.04 M	986 K	1.09 M	908 K	652 K	447 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
11.1 M	447 K	2.92 M

Quarterly Depreciation & Amortization Avid Bioservices

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
6.8 M	2.82 M	8.25 M	5.43 M	2.65 M	2.8 M	5.33 M	2.65 M	1.59 M	1.9 M	3.06 M	3.41 M	-	900 K	2.54 M	1.68 M	1.01 M	800 K	800 K	700 K	726 K	700 K	681 K	683 K	642 K	645 K	645 K	658 K	642 K	631 K	631 K	606 K	613 K	464 K	464 K	223 K	234 K	261 K	261 K	265 K	277 K	244 K	244 K	236 K	257 K	280 K	280 K	266 K	260 K	238 K	664 K	426 K	203 K	-	223 K	203 K	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
8.25 M	203 K	1.3 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	2.1 M	-	-	$ 2.18 B	USA
Alpine Immune Sciences ALPN	576 K	-	-	$ 2.17 B	USA
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Compugen Ltd. CGEN	475 K	$ 2.02	-	$ 189 M	Israel
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Coherus BioSciences CHRS	1.3 M	$ 1.42	-	$ 166 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 51.48	-	$ 4.63 B	Schweiz
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	3.38 M	$ 29.6	-	$ 1.97 B	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Enlivex Therapeutics Ltd. ENLV	332 K	$ 0.69	-	$ 31.5 M	Israel
Eton Pharmaceuticals ETON	4.04 M	$ 30.53	1.94 %	$ 821 M	USA
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
Exelixis EXEL	29.1 M	$ 52.99	-	$ 14.4 B	USA
Gracell Biotechnologies GRCL	58.8 M	-	-	$ 3.37 B	China
Forte Biosciences FBRX	64 K	$ 17.0	8.49 %	$ 220 M	USA
Anika Therapeutics ANIK	5.37 M	$ 14.57	-	$ 209 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.91	-	$ 4.79 M	Israel
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA